Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04819594 · ClinicalTrials.gov registry record · NA
The Effects of Aromatherapy on the Stress Levels of Nurses Working in an Urban, Safety-Net Community Hospital
A NA study of Stress Levels, sponsored by Parkland Health and Hospital System.
- Completed
- Registry status
- NA
- Development phase
- 319
- Enrollment target
- 1
- Study location
NCT04819594: Completed NA study of Stress Levels, sponsored by Parkland Health and Hospital System.
NCT04819594 is a NA study of Stress Levels that has completed, run by Parkland Health and Hospital System. The registered enrollment target is 319 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04819594, a NA study of Stress Levels, has completed, sponsored by Parkland Health and Hospital System.
- COMPLETED
- Registry status
- NA
- Development phase
- 319 participants
- Enrollment target
- 1
- Study location
Study Summary
Parkland Hospital inpatient nursing staff will be the focus of this study. This project aims to investigate the use of lavender on the stress levels associated with the nursing role. Nurses will wear the Elequil aromatabs ® over a four-hour period and a post survey will be given to assess root cause of stress and changes related to intervention.
Primary Outcome
Nurse Survey is used for measuring the level of stress in nurses who agree that the intervention reduced their stress levels. Possible scores range from 0 - 10 with higher scores indicating severe stress levels (worse outcome).
Conditions Studied
Interventions
- OTHER Elequil aromatabs ®
Study Locations (1)
Texas
- Parkland Health and Hospital System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT04819594 record still lists
NCT04819594 is an interventional study that assigns participants to a tested intervention. The registered 319 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Stress Levels appearing as the primary indexed condition, and to 1 intervention - of which Elequil aromatabs ® is the first listed.
NCT04819594 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04819594 about?
NCT04819594 is a clinical study titled "The Effects of Aromatherapy on the Stress Levels of Nurses Working in an Urban, Safety-Net Community Hospital". Parkland Hospital inpatient nursing staff will be the focus of this study. This project aims to investigate the use of lavender on the stress levels associated with the nursing role. Nurses will wear the Elequil aromatabs ® over a four-hour period and a post survey will be given to assess root cause...
What is the current status of trial NCT04819594?
This trial is currently completed. It is a NA study. The enrollment target is 319 participants. The study started on 2021-06-01. Estimated completion is 2021-10-31.
What conditions does trial NCT04819594 study?
This clinical trial studies the following conditions: Stress Levels.
What interventions are being tested in trial NCT04819594?
The interventions under investigation include: Elequil aromatabs ® (OTHER).
Who is sponsoring clinical trial NCT04819594?
This trial is sponsored by Parkland Health and Hospital System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04819594 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Levels
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04819594's enrollment target sits among peer trials
319 321st of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05377996 · 319 participants · Phase 1
A Study of XMT-1660 in Participants With Solid Tumors
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI